Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia

Pediatric Infectious Disease Journal

Volumn 18, Issue 6, 1999, Pages 524-528

  Isaacs, David ^a   Royle, Jennifer A ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Aboriginal infants; Australia; Early onset; Group B Streptococcus; Intrapartum antibiotics; Neonatal infection

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN;

ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BLOOD CULTURE; CEREBROSPINAL FLUID EXAMINATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; URINE CULTURE;

ANTI-BACTERIAL AGENTS; AUSTRALIA; DISEASE TRANSMISSION, VERTICAL; DRUG UTILIZATION; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; LONGITUDINAL STUDIES; OCEANIC ANCESTRY GROUP; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0033031305     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199906000-00009     Document Type: Article

References (16)

1. Garland SM, Fliegner JR. Group B Streptococcus and neonatal infections: the case for intrapartum chemoprophylaxis. Aust NZ J Obstet Gynaecol 1991;31:119-22.
2. Isaacs D, Barfield C, Grimwood K, et al. Systemic bacterial and fungal infections in infants in Australian neonatal units. Med J Aust 1995;162:198-201.
3. Australasian Study Group for Neonatal Infections. Early onset group B streptococcal infections in Aboriginal and non-Aboriginal infants. Med J Aust 1995;163:302-6.
4. Jeffery HE, Lahra MM. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics 1998;101:1-6.
5. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 1992;41(55-6):25-32.
6. Gilbert GL, Isaacs D, Burgess M, et al. Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate? Aust NZ J Obstet Gynaecol 1995;35:120-6.
7. Centers for Disease Control. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45(RR-7):1-24.
8. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-96.
9. Gardner MJ, Altman DG. Statistics with confidence. London: BMJ Publications, 1989.
10. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO. Infectious diseases of the fetus and new born infant. 4th ed. Philadelphia: Saunders, 1995:980-1054.
11. Lahra MM, Heath P, Wilkinson AR, Jeffery HE, Isaacs D. Early-onset group B streptococcal neonatal infection in Oxford. Arch Dis Child Fetal Neonatal Ed 1998;79:F148-9.
12. Jeffery HE, McIntosh EDG. Antepartum screening and non-selective intrapartum chemoprophylaxis for group B Streptococcus Aust NZ J Obstet Gynecol 1994;34:14-9.
13. McIntosh EDG, Jeffery HE. Clinical application of urine antigen detection in early onset group B streptococcal disease. Arch Dis Child 1992;67:1198-200.
14. Williamson M, Fraser SH, Tilse M. Failure of the urinary group B streptococcal antigen test as a screen for neonatal sepsis. Arch Dis Child 1995;73:F109-11.
15. Mohle-Boetani JC, Schuchat A, Plikyatis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis. JAMA 1993;270:1442-8.
16. Isaacs D. Prevention of early onset group B streptococcal infection: screen, treat or observe? Arch Dis Child Fetal Neonatal Ed 1998;79:F81-2.